Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Worms for immune regulation of multiple sclerosis
2008-005008-24Phase 2Completed
- Sponsor
- University of Nottingham
- Start
- May 2011
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in relapsing-remitting multiple sclerosis (RRMS) comparing Necator americanus with Placebo (2 arms). Primary endpoint: Cumulative number of new or enlarging gadolinium-enhancing lesions at month 9. Started May 2011; status: completed.
02
Drugs
Necator americanus larvae
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on 2008-005008-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005008-24.